Cargando…
Systematic review: cystic fibrosis in the SARS-CoV-2/COVID-19 pandemic
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the development of life-threatening COVID-19 are believed to disproportionately affect certain at-risk populations. However, it is not clear whether individuals with cystic fibrosis (CF) are at a higher risk of CO...
Autores principales: | Mathew, Hannah R., Choi, May Y., Parkins, Michael D., Fritzler, Marvin J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135381/ https://www.ncbi.nlm.nih.gov/pubmed/34016096 http://dx.doi.org/10.1186/s12890-021-01528-0 |
Ejemplares similares
-
Cytokine autoantibodies in SARS-CoV-2 prepandemic and intrapandemic samples from an SLE cohort
por: Choi, May Y, et al.
Publicado: (2022) -
SARS-CoV-2 seroprevalence, seroconversion and neutralizing antibodies in a systemic lupus erythematosus cohort and comparison to controls
por: Mathew, Hannah R, et al.
Publicado: (2021) -
SARS-CoV-2 Infection in patients with cystic fibrosis. An overwiew
por: Fainardi, Valentina, et al.
Publicado: (2020) -
The global impact of SARS-CoV-2 in 181 people with cystic fibrosis
por: McClenaghan, Elliot, et al.
Publicado: (2020) -
P163 Effects of the SARS-CoV-2 pandemic on attendance at the cystic fibrosis centre and the definition of the microbiological status of cystic fibrosis patients in Tuscany
por: Dolce, D., et al.
Publicado: (2021)